Canada's import value of antibiotics is forecasted to gradually decline from $167.23 million in 2024 to $162.96 million by 2028. Comparing 2024 to previous years, the data indicates a consistent downward trend. From 2023 to 2024, the year-on-year variation shows a slight decrease, with subsequent years following a similar pattern. The Compound Annual Growth Rate (CAGR) over the five-year span is negative, affirming this overall declining trend.

Future trends to watch for:

Potential changes in global demand and supply dynamics for antibiotics.
Impact of new trade agreements or regulatory changes.
Advancements in pharmaceutical alternatives that might affect import volumes.
Fluctuations in Canadian healthcare policies influencing antibiotic importation needs.